-
1
-
-
47849125899
-
Heart failure-related hospitalization in the U.S., 1979 to 2004
-
J. Fang, G.A. Mensah, and J.B. Croft Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 428-434
-
-
Fang, J.1
Mensah, G.A.2
Croft, J.B.3
-
2
-
-
33747065311
-
Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure
-
M.F. Piepoli, A. Kaczmarek, and D.P. Francis Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure Circulation 114 2006 126 134
-
(2006)
Circulation
, vol.114
, pp. 126-134
-
-
Piepoli, M.F.1
Kaczmarek, A.2
Francis, D.P.3
-
4
-
-
33845565186
-
Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure
-
S. von Haehling, W. Doehner, and S.D. Anker Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure Cardiovasc Res 73 2007 298 309
-
(2007)
Cardiovasc Res
, vol.73
, pp. 298-309
-
-
Von Haehling, S.1
Doehner, W.2
Anker, S.D.3
-
5
-
-
0342460492
-
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
-
S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534
-
(1997)
Circulation
, vol.96
, pp. 526-534
-
-
Anker, S.D.1
Chua, T.P.2
Ponikowski, P.3
-
6
-
-
33750548421
-
Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival
-
E.A. Jankowska, B. Biel, and J. Majda Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
-
(2006)
Circulation
, vol.114
, pp. 1829-1837
-
-
Jankowska, E.A.1
Biel, B.2
Majda, J.3
-
7
-
-
50349087339
-
Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake
-
S.E. Malmberg, and C.M. Adams Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake J Biol Chem 283 2008 19229 19234
-
(2008)
J Biol Chem
, vol.283
, pp. 19229-19234
-
-
Malmberg, S.E.1
Adams, C.M.2
-
8
-
-
78649844780
-
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: Relationship with markers of immune activation
-
M.J. Toth, M.M. LeWinter, and P.A. Ades Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation Clin Sci (Lond) 119 2010 467 476
-
(2010)
Clin Sci (Lond)
, vol.119
, pp. 467-476
-
-
Toth, M.J.1
Lewinter, M.M.2
Ades, P.A.3
-
9
-
-
33747619854
-
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling
-
X. Wang, Z. Hu, and J. Hu Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling Endocrinology 147 2006 4160 4168
-
(2006)
Endocrinology
, vol.147
, pp. 4160-4168
-
-
Wang, X.1
Hu, Z.2
Hu, J.3
-
10
-
-
0030751957
-
Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure
-
J.W. Swan, S.D. Anker, and C. Walton Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 527-532
-
-
Swan, J.W.1
Anker, S.D.2
Walton, C.3
-
11
-
-
24944519346
-
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
-
W. Doehner, M. Rauchhaus, and P. Ponikowski Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1019-1026
-
-
Doehner, W.1
Rauchhaus, M.2
Ponikowski, P.3
-
12
-
-
7244254468
-
Impaired glucose metabolism in patients with heart failure: Pathophysiology and possible treatment strategies
-
A. Tenenbaum, and E.Z. Fisman Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies Am J Cardiovasc Drugs 4 2004 269 280
-
(2004)
Am J Cardiovasc Drugs
, vol.4
, pp. 269-280
-
-
Tenenbaum, A.1
Fisman, E.Z.2
-
13
-
-
0036230154
-
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
-
W. Doehner, M. Rauchhaus, and I.F. Godsland Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha Int J Cardiol 83 2002 73 81
-
(2002)
Int J Cardiol
, vol.83
, pp. 73-81
-
-
Doehner, W.1
Rauchhaus, M.2
Godsland, I.F.3
-
14
-
-
0035210722
-
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
-
W. Doehner, C.D. Pflaum, and M. Rauchhaus Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia Eur J Endocrinol 145 2001 727 735
-
(2001)
Eur J Endocrinol
, vol.145
, pp. 727-735
-
-
Doehner, W.1
Pflaum, C.D.2
Rauchhaus, M.3
-
15
-
-
0034897735
-
Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone
-
S.D. Anker, M. Volterrani, and C.D. Pflaum Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone J Am Coll Cardiol 38 2001 443 452
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 443-452
-
-
Anker, S.D.1
Volterrani, M.2
Pflaum, C.D.3
-
16
-
-
0032565361
-
Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
-
K.J. Osterziel, O. Strohm, and J. Schuler Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy Lancet 351 1998 1233 1237
-
(1998)
Lancet
, vol.351
, pp. 1233-1237
-
-
Osterziel, K.J.1
Strohm, O.2
Schuler, J.3
-
17
-
-
67349180243
-
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure
-
E.A. Jankowska, G. Filippatos, and B. Ponikowska Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure J Card Fail 15 2009 442 450
-
(2009)
J Card Fail
, vol.15
, pp. 442-450
-
-
Jankowska, E.A.1
Filippatos, G.2
Ponikowska, B.3
-
18
-
-
0035940390
-
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: Relationships between ghrelin and anabolic/catabolic factors
-
N. Nagaya, M. Uematsu, and M. Kojima Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 104 2001 2034 2038
-
(2001)
Circulation
, vol.104
, pp. 2034-2038
-
-
Nagaya, N.1
Uematsu, M.2
Kojima, M.3
-
19
-
-
60449091233
-
Resistin, adiponectin, and risk of heart failure the Framingham offspring study
-
D.S. Frankel, R.S. Vasan, and R.B. D'Agostino Sr. Resistin, adiponectin, and risk of heart failure the Framingham offspring study J Am Coll Cardiol 53 2009 754 762
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 754-762
-
-
Frankel, D.S.1
Vasan, R.S.2
D'Agostino, R.B.3
-
20
-
-
84894252588
-
Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis
-
T. Szabó, N. Scherbakov, and A. Sandek Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis Nutr Metab Cardiovasc Dis 24 2014 50 56
-
(2014)
Nutr Metab Cardiovasc Dis
, vol.24
, pp. 50-56
-
-
Szabó, T.1
Scherbakov, N.2
Sandek, A.3
-
21
-
-
21244431648
-
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
-
A.L. Birkenfeld, M. Boschmann, and C. Moro Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans J Clin Endocrinol Metab 90 2005 3622 3628
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 3622-3628
-
-
Birkenfeld, A.L.1
Boschmann, M.2
Moro, C.3
-
22
-
-
34948814651
-
Altered intestinal function in patients with chronic heart failure
-
A. Sandek, J. Bauditz, and A. Swidsinski Altered intestinal function in patients with chronic heart failure J Am Coll Cardiol 50 2007 1561 1569
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1561-1569
-
-
Sandek, A.1
Bauditz, J.2
Swidsinski, A.3
-
23
-
-
67651237070
-
Exercise training, energy metabolism, and heart failure
-
R. Ventura-Clapier Exercise training, energy metabolism, and heart failure Appl Physiol Nutr Metab 34 2009 336 339
-
(2009)
Appl Physiol Nutr Metab
, vol.34
, pp. 336-339
-
-
Ventura-Clapier, R.1
-
24
-
-
44649151707
-
The PPAR trio: Regulators of myocardial energy metabolism in health and disease
-
J.A. Madrazo, and D.P. Kelly The PPAR trio: regulators of myocardial energy metabolism in health and disease J Mol Cell Cardiol 44 2008 968 975
-
(2008)
J Mol Cell Cardiol
, vol.44
, pp. 968-975
-
-
Madrazo, J.A.1
Kelly, D.P.2
-
25
-
-
0038637236
-
Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure
-
P.C. Schulze, S. Gielen, and V. Adams Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure Basic Res Cardiol 98 2003 267 274
-
(2003)
Basic Res Cardiol
, vol.98
, pp. 267-274
-
-
Schulze, P.C.1
Gielen, S.2
Adams, V.3
-
26
-
-
14844292158
-
Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: A chimaeric view of inflammation?
-
L.D. Libera, and G. Vescovo Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr Opin Clin Nutr Metab Care 7 2004 435 441
-
(2004)
Curr Opin Clin Nutr Metab Care
, vol.7
, pp. 435-441
-
-
Libera, L.D.1
Vescovo, G.2
-
27
-
-
79958064409
-
Myostatin from the heart: Local and systemic actions in cardiac failure and muscle wasting
-
A. Breitbart, M. Auger-Messier, and J.D. Molkentin Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Am J Physiol Heart Circ Physiol 300 2011 H1973 H1982
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
, pp. 1973-H1982
-
-
Breitbart, A.1
Auger-Messier, M.2
Molkentin, J.D.3
-
28
-
-
11144247719
-
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle
-
S. Girgenrath, K. Song, and L.A. Whittemore Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle Muscle Nerve 31 2005 34 40
-
(2005)
Muscle Nerve
, vol.31
, pp. 34-40
-
-
Girgenrath, S.1
Song, K.2
Whittemore, L.A.3
-
29
-
-
38749120993
-
Hypothesis: Myostatin is a mediator of cardiac cachexia
-
M.R. Hoenig Hypothesis: myostatin is a mediator of cardiac cachexia Int J Cardiol 124 2008 131 133
-
(2008)
Int J Cardiol
, vol.124
, pp. 131-133
-
-
Hoenig, M.R.1
-
30
-
-
0026554586
-
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
-
D.M. Mancini, G. Walter, and N. Reichek Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure Circulation 85 1992 1364 1373
-
(1992)
Circulation
, vol.85
, pp. 1364-1373
-
-
Mancini, D.M.1
Walter, G.2
Reichek, N.3
-
31
-
-
0031539407
-
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure
-
D. Harrington, S.D. Anker, and T.P. Chua Skeletal muscle function and its relation to exercise tolerance in chronic heart failure J Am Coll Cardiol 30 1997 1758 1764
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 1758-1764
-
-
Harrington, D.1
Anker, S.D.2
Chua, T.P.3
-
32
-
-
19044393872
-
Adipose tissue, inflammation, and cardiovascular disease
-
A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ Res 96 2005 939 949
-
(2005)
Circ Res
, vol.96
, pp. 939-949
-
-
Berg, A.H.1
Scherer, P.E.2
-
33
-
-
33846621473
-
Fat loss in cachexia - Is there a role for adipocyte lipolysis?
-
M. Rydén, and P. Arner Fat loss in cachexia - is there a role for adipocyte lipolysis? Clin Nutr 26 2007 1 6
-
(2007)
Clin Nutr
, vol.26
, pp. 1-6
-
-
Rydén, M.1
Arner, P.2
-
35
-
-
0033936322
-
Natriuretic peptides: A new lipolytic pathway in human adipocytes
-
C. Sengenès, M. Berlan, and I. De Glisezinski Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J 14 2000 1345 1351
-
(2000)
FASEB J
, vol.14
, pp. 1345-1351
-
-
Sengenès, C.1
Berlan, M.2
De Glisezinski, I.3
-
36
-
-
42949109612
-
Control of lipolysis by natriuretic peptides and cyclic GMP
-
M. Lafontan, C. Moro, and M. Berlan Control of lipolysis by natriuretic peptides and cyclic GMP Trends Endocrinol Metab 19 2008 130 137
-
(2008)
Trends Endocrinol Metab
, vol.19
, pp. 130-137
-
-
Lafontan, M.1
Moro, C.2
Berlan, M.3
-
37
-
-
84885051569
-
Increased catabolic activity in adipose tissue of patients with chronic heart failure
-
T. Szabó, E. Postrach, and A. Mähler Increased catabolic activity in adipose tissue of patients with chronic heart failure Eur J Heart Fail 15 2013 1131 1137
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1131-1137
-
-
Szabó, T.1
Postrach, E.2
Mähler, A.3
-
38
-
-
20344400660
-
Adipocyte signaling and lipid homeostasis: Sequelae of insulin-resistant adipose tissue
-
Y.H. Yu, and H.N. Ginsberg Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue Circ Res 96 2005 1042 1052
-
(2005)
Circ Res
, vol.96
, pp. 1042-1052
-
-
Yu, Y.H.1
Ginsberg, H.N.2
-
39
-
-
25444506344
-
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
-
C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
-
(2005)
Circulation
, vol.112
, pp. 1756-1762
-
-
Kistorp, C.1
Faber, J.2
Galatius, S.3
-
40
-
-
34548355070
-
Increase in serum adiponectin concentration in patients with heart failure and cachexia: Relationship with leptin, other cytokines, and B-type natriuretic peptide
-
M.B. McEntegart, B. Awede, and M.C. Petrie Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 2007 829 835
-
(2007)
Eur Heart J
, vol.28
, pp. 829-835
-
-
McEntegart, M.B.1
Awede, B.2
Petrie, M.C.3
-
41
-
-
0030852304
-
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
-
E. Shane, D. Mancini, and K. Aaronson Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure Am J Med 103 1997 197 207
-
(1997)
Am J Med
, vol.103
, pp. 197-207
-
-
Shane, E.1
Mancini, D.2
Aaronson, K.3
-
42
-
-
67649794856
-
Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden
-
S. Abou-Raya, and A. Abou-Raya Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden Arch Gerontol Geriatr 49 2009 250 254
-
(2009)
Arch Gerontol Geriatr
, vol.49
, pp. 250-254
-
-
Abou-Raya, S.1
Abou-Raya, A.2
-
43
-
-
0033557630
-
Loss of bone mineral in patients with cachexia due to chronic heart failure
-
S.D. Anker, A.L. Clark, and M.M. Teixeira Loss of bone mineral in patients with cachexia due to chronic heart failure Am J Cardiol 83 1999 612 615
-
(1999)
Am J Cardiol
, vol.83
, pp. 612-615
-
-
Anker, S.D.1
Clark, A.L.2
Teixeira, M.M.3
-
44
-
-
62449231008
-
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants
-
E.A. Jankowska, J. Jakubaszko, and A. Cwynar Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants Eur J Heart Fail 11 2009 28 38
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 28-38
-
-
Jankowska, E.A.1
Jakubaszko, J.2
Cwynar, A.3
-
46
-
-
77950034070
-
Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure
-
B. Bozic, G. Loncar, and N. Prodanovic Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure J Card Fail 16 2010 301 307
-
(2010)
J Card Fail
, vol.16
, pp. 301-307
-
-
Bozic, B.1
Loncar, G.2
Prodanovic, N.3
-
47
-
-
0036342402
-
Cardiac cachexia in early literature: A review of research prior to Medline
-
W. Doehner, and S.D. Anker Cardiac cachexia in early literature: a review of research prior to Medline Int J Cardiol 85 2002 7 14
-
(2002)
Int J Cardiol
, vol.85
, pp. 7-14
-
-
Doehner, W.1
Anker, S.D.2
-
48
-
-
0030972278
-
Wasting as independent risk factor for mortality in chronic heart failure
-
S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
-
(1997)
Lancet
, vol.349
, pp. 1050-1053
-
-
Anker, S.D.1
Ponikowski, P.2
Varney, S.3
-
49
-
-
78650411136
-
Cachexia as a major underestimated and unmet medical need: Facts and numbers
-
S. von Haehling, and S.D. Anker Cachexia as a major underestimated and unmet medical need: facts and numbers J Cachexia Sarcopenia Muscle 1 2010 1 5
-
(2010)
J Cachexia Sarcopenia Muscle
, vol.1
, pp. 1-5
-
-
Von Haehling, S.1
Anker, S.D.2
-
50
-
-
77950340105
-
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics."
-
M. Muscaritoli, S.D. Anker, and J. Argilés Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin Nutr 29 2010 154 159
-
(2010)
Clin Nutr
, vol.29
, pp. 154-159
-
-
Muscaritoli, M.1
Anker, S.D.2
Argilés, J.3
-
51
-
-
0037471843
-
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study
-
S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
-
(2003)
Lancet
, vol.361
, pp. 1077-1083
-
-
Anker, S.D.1
Negassa, A.2
Coats, A.J.3
-
55
-
-
67149084949
-
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications
-
I. Theurl, E. Aigner, and M. Theurl Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood 113 2009 5277 5286
-
(2009)
Blood
, vol.113
, pp. 5277-5286
-
-
Theurl, I.1
Aigner, E.2
Theurl, M.3
-
56
-
-
77954249308
-
Two to tango: Regulation of Mammalian iron metabolism
-
M.W. Hentze, M.U. Muckenthaler, and B. Galy Two to tango: regulation of Mammalian iron metabolism Cell 142 2010 24 38
-
(2010)
Cell
, vol.142
, pp. 24-38
-
-
Hentze, M.W.1
Muckenthaler, M.U.2
Galy, B.3
-
57
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
E. Nemeth, S. Rivera, and V. Gabayan IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 2004 1271 1276
-
(2004)
J Clin Invest
, vol.113
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
-
58
-
-
65349173063
-
Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli
-
H. Huang, M. Constante, and A. Layoun Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli Blood 113 2009 3593 3599
-
(2009)
Blood
, vol.113
, pp. 3593-3599
-
-
Huang, H.1
Constante, M.2
Layoun, A.3
-
59
-
-
0037458095
-
Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure
-
J.A. Ezekowitz, F.A. McAlister, and P.W. Armstrong Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure Circulation 107 2003 223 225
-
(2003)
Circulation
, vol.107
, pp. 223-225
-
-
Ezekowitz, J.A.1
McAlister, F.A.2
Armstrong, P.W.3
-
60
-
-
14744278436
-
Anemia of chronic disease
-
G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
-
(2005)
N Engl J Med
, vol.352
, pp. 1011-1023
-
-
Weiss, G.1
Goodnough, L.T.2
-
61
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
for the FAIR-HF Trial Investigators
-
S.D. Anker, J. Comin Colet, G. Filippatos for the FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
-
(2009)
N Engl J Med
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin Colet, J.2
Filippatos, G.3
-
62
-
-
80155190205
-
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure
-
E.A. Jankowska, P. Rozentryt, and A. Witkowska Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure J Card Fail 17 2011 899 906
-
(2011)
J Card Fail
, vol.17
, pp. 899-906
-
-
Jankowska, E.A.1
Rozentryt, P.2
Witkowska, A.3
-
63
-
-
33751177803
-
Iron-sulfur protein biogenesis in eukaryotes: Components and mechanisms
-
R. Lill, and U. Muhlenhoff Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms Annu Rev Cell Dev Biol 22 2006 457 486
-
(2006)
Annu Rev Cell Dev Biol
, vol.22
, pp. 457-486
-
-
Lill, R.1
Muhlenhoff, U.2
-
64
-
-
80155135813
-
Mitochondrial mayhem: The mitochondrion as a modulator of iron metabolism and its role in disease
-
M.L. Huang, D.J. Lane, and D.R. Richardson Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease Antioxid Redox Signal 15 2011 3003 3019
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 3003-3019
-
-
Huang, M.L.1
Lane, D.J.2
Richardson, D.R.3
-
65
-
-
0035040884
-
Uric acid in cachectic and non-cachectic patients with chronic heart failure: Relationship to leg vascular resistance
-
W. Doehner, M. Rauchhaus, and V.G. Florea Uric acid in cachectic and non-cachectic patients with chronic heart failure: relationship to leg vascular resistance Am Heart J 141 2001 792 799
-
(2001)
Am Heart J
, vol.141
, pp. 792-799
-
-
Doehner, W.1
Rauchhaus, M.2
Florea, V.G.3
-
66
-
-
0037461111
-
Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging
-
S.D. Anker, W. Doehner, and M. Rauchhaus Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
-
(2003)
Circulation
, vol.107
, pp. 1991-1997
-
-
Anker, S.D.1
Doehner, W.2
Rauchhaus, M.3
-
67
-
-
33645827323
-
The Seattle Heart Failure Model: Prediction of survival in heart failure
-
W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
-
(2006)
Circulation
, vol.113
, pp. 1424-1433
-
-
Levy, W.C.1
Mozaffarian, D.2
Linker, D.T.3
-
68
-
-
0031723208
-
Uric acid in chronic heart failure: A measure of the anaerobic threshold
-
F. Leyva, T.P. Chua, and S.D. Anker Uric acid in chronic heart failure: a measure of the anaerobic threshold Metabolism 47 1998 1156 1159
-
(1998)
Metabolism
, vol.47
, pp. 1156-1159
-
-
Leyva, F.1
Chua, T.P.2
Anker, S.D.3
-
69
-
-
0031779935
-
The glycolytic pathway to coronary heart disease: A hypothesis
-
F. Leyva, C.S. Wingrove, and I.F. Godsland The glycolytic pathway to coronary heart disease: a hypothesis Metabolism 47 1998 657 662
-
(1998)
Metabolism
, vol.47
, pp. 657-662
-
-
Leyva, F.1
Wingrove, C.S.2
Godsland, I.F.3
-
70
-
-
0027585643
-
Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: An immunocytochemical study
-
M. Ashraf, and Z.Q. Samra Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study J Submicrosc Cytol Pathol 25 1993 193 201
-
(1993)
J Submicrosc Cytol Pathol
, vol.25
, pp. 193-201
-
-
Ashraf, M.1
Samra, Z.Q.2
-
71
-
-
80054069941
-
Xanthine oxidase and uric acid in cardiovascular disease: Clinical impact and therapeutic options
-
W. Doehner, and U. Landmesser Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options Semin Nephrol 31 2011 433 440
-
(2011)
Semin Nephrol
, vol.31
, pp. 433-440
-
-
Doehner, W.1
Landmesser, U.2
-
72
-
-
33846446393
-
Uric acid in CHF: Marker or player in a metabolic disease?
-
W. Doehner, S. von Haehling, and S.D. Anker Uric acid in CHF: marker or player in a metabolic disease? Int J Cardiol 115 2007 156 158
-
(2007)
Int J Cardiol
, vol.115
, pp. 156-158
-
-
Doehner, W.1
Von Haehling, S.2
Anker, S.D.3
-
73
-
-
76549098607
-
Uric acid-lowering treatment with benzbromarone in patients with heart failure: A double blind placebo-controlled cross-over preliminary study
-
K. Ogino, M. Kato, and Y. Furuse Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double blind placebo-controlled cross-over preliminary study Circ Heart Fail 3 2010 73 81
-
(2010)
Circ Heart Fail
, vol.3
, pp. 73-81
-
-
Ogino, K.1
Kato, M.2
Furuse, Y.3
-
74
-
-
35848962497
-
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes
-
W.S. Waring, J.A. McKnight, and D.J. Webb Lowering serum urate does not improve endothelial function in patients with type 2 diabetes Diabetologia 50 2007 2572 2579
-
(2007)
Diabetologia
, vol.50
, pp. 2572-2579
-
-
Waring, W.S.1
McKnight, J.A.2
Webb, D.J.3
-
75
-
-
0034095332
-
Myocardial substrate metabolism influences left ventricular energetics in vivo
-
C. Korvald, O.P. Elvenes, and T. Myrmel Myocardial substrate metabolism influences left ventricular energetics in vivo Am J Physiol Heart Circ Physiol 278 2000 H1345 H1351
-
(2000)
Am J Physiol Heart Circ Physiol
, vol.278
, pp. 1345-H1351
-
-
Korvald, C.1
Elvenes, O.P.2
Myrmel, T.3
-
76
-
-
0028302261
-
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate
-
R.M. Bersin, C. Wolfe, and M. Kwasman Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate J Am Coll Cardiol 23 1994 1617 1624
-
(1994)
J Am Coll Cardiol
, vol.23
, pp. 1617-1624
-
-
Bersin, R.M.1
Wolfe, C.2
Kwasman, M.3
-
77
-
-
33751002633
-
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure
-
H. Tuunanen, E. Engblom, and A. Naum Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure Circulation 114 2006 2130 2137
-
(2006)
Circulation
, vol.114
, pp. 2130-2137
-
-
Tuunanen, H.1
Engblom, E.2
Naum, A.3
-
78
-
-
77749273703
-
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
-
M. Halbirk, H. Nørrelund, and N. Møller Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure Am J Physiol Heart Circ Physiol 298 2010 H1096 H1102
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.298
, pp. 1096-H1102
-
-
Halbirk, M.1
Nørrelund, H.2
Møller, N.3
-
79
-
-
28144459335
-
Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia
-
W.C. Stanley, E.E. Morgan, and H. Huang Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia Am J Physiol Heart Circ Physiol 289 2005 H2304 H2309
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
, pp. 2304-H2309
-
-
Stanley, W.C.1
Morgan, E.E.2
Huang, H.3
-
80
-
-
0030602865
-
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
-
J.A. Kennedy, S.A. Unger, and J.D. Horowitz Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone Biochem Pharmacol 52 1996 273 280
-
(1996)
Biochem Pharmacol
, vol.52
, pp. 273-280
-
-
Kennedy, J.A.1
Unger, S.A.2
Horowitz, J.D.3
-
81
-
-
21144453386
-
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure
-
V. Lionetti, A. Linke, and M.P. Chandler Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure Cardiovasc Res 66 2005 454 461
-
(2005)
Cardiovasc Res
, vol.66
, pp. 454-461
-
-
Lionetti, V.1
Linke, A.2
Chandler, M.P.3
-
82
-
-
70349658838
-
The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo
-
M. Schwarzer, G. Faerber, and T. Rueckauer The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo Basic Res Cardiol 104 2009 547 557
-
(2009)
Basic Res Cardiol
, vol.104
, pp. 547-557
-
-
Schwarzer, M.1
Faerber, G.2
Rueckauer, T.3
-
83
-
-
0033910352
-
First clinical trial with etomoxir in patients with chronic congestive heart failure
-
S. Schmidt-Schweda, and C. Holubarsch First clinical trial with etomoxir in patients with chronic congestive heart failure Clin Sci (Lond) 99 2000 27 35
-
(2000)
Clin Sci (Lond)
, vol.99
, pp. 27-35
-
-
Schmidt-Schweda, S.1
Holubarsch, C.2
-
84
-
-
34547800233
-
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: The ERGO (etomoxir for the recovery of glucose) study
-
C.J. Holubarsch, M. Rohrbach, and M. Karrasch A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose) study Clin Sci (Lond) 113 2007 205 212
-
(2007)
Clin Sci (Lond)
, vol.113
, pp. 205-212
-
-
Holubarsch, C.J.1
Rohrbach, M.2
Karrasch, M.3
-
85
-
-
0022451358
-
Perhexiline maleate treatment for severe angina pectoris-correlations with pharmacokinetics
-
J.D. Horowitz, S.T. Sia, and P.S. Macdonald Perhexiline maleate treatment for severe angina pectoris-correlations with pharmacokinetics Int J Cardiol 13 1986 219 229
-
(1986)
Int J Cardiol
, vol.13
, pp. 219-229
-
-
Horowitz, J.D.1
Sia, S.T.2
Macdonald, P.S.3
-
86
-
-
33644875657
-
Metabolic modulation with perhexiline in chronic heart failure: A randomized, controlled trial of short-term use of a novel treatment
-
L. Lee, R. Campbell, and M. Scheuermann-Freestone Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment Circulation 112 2005 3280 3288
-
(2005)
Circulation
, vol.112
, pp. 3280-3288
-
-
Lee, L.1
Campbell, R.2
Scheuermann-Freestone, M.3
-
87
-
-
78049509377
-
Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy
-
K. Abozguia, P. Elliott, and W. McKenna Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy Circulation 122 2010 1562 1569
-
(2010)
Circulation
, vol.122
, pp. 1562-1569
-
-
Abozguia, K.1
Elliott, P.2
McKenna, W.3
-
88
-
-
32044448471
-
Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation
-
J.A. Kennedy, K. Beck-Oldach, and K. McFadden-Lewis Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation Eur J Pharmacol 531 2006 13 19
-
(2006)
Eur J Pharmacol
, vol.531
, pp. 13-19
-
-
Kennedy, J.A.1
Beck-Oldach, K.2
McFadden-Lewis, K.3
-
89
-
-
84874470810
-
How does perhexiline modulate myocardial energetics and ameliorate redox stress (abstr)?
-
D.T. Ngo, N.E. Drury, and D. Pagano How does perhexiline modulate myocardial energetics and ameliorate redox stress (abstr)? Circulation 124 2011 A14461
-
(2011)
Circulation
, vol.124
, pp. 14461
-
-
Ngo, D.T.1
Drury, N.E.2
Pagano, D.3
-
90
-
-
70349616273
-
Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling
-
A.D. Balgi, B.D. Fonseca, and E. Donohue Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling PLoS One 4 2009 e7124
-
(2009)
PLoS One
, vol.4
, pp. 7124
-
-
Balgi, A.D.1
Fonseca, B.D.2
Donohue, E.3
-
91
-
-
0031827967
-
Beta-receptor blockade decreases carnitine palmitoyl transferase i activity in dogs with heart failure
-
A.R. Panchal, W.C. Stanley, and J. Kerner Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure J Card Fail 4 1998 121 126
-
(1998)
J Card Fail
, vol.4
, pp. 121-126
-
-
Panchal, A.R.1
Stanley, W.C.2
Kerner, J.3
-
92
-
-
0035933194
-
Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure
-
T.R. Wallhaus, M. Taylor, and T.R. DeGrado Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure Circulation 103 2001 2441 2446
-
(2001)
Circulation
, vol.103
, pp. 2441-2446
-
-
Wallhaus, T.R.1
Taylor, M.2
Degrado, T.R.3
-
93
-
-
0029150294
-
Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy
-
Y. Kusaka, T. Tanaka, and F. Okamoto Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy J Mol Cell Cardiol 27 1995 1605 1612
-
(1995)
J Mol Cell Cardiol
, vol.27
, pp. 1605-1612
-
-
Kusaka, Y.1
Tanaka, T.2
Okamoto, F.3
-
94
-
-
0034678082
-
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
-
P.F. Kantor, A. Lucien, and R. Kozak The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circ Res 86 2000 580 588
-
(2000)
Circ Res
, vol.86
, pp. 580-588
-
-
Kantor, P.F.1
Lucien, A.2
Kozak, R.3
-
95
-
-
53449101397
-
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy
-
H. Tuunanen, E. Engblom, and A. Naum Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy Circulation 118 2008 1250 1258
-
(2008)
Circulation
, vol.118
, pp. 1250-1258
-
-
Tuunanen, H.1
Engblom, E.2
Naum, A.3
-
96
-
-
84863243325
-
Additional use of trimetazidine in patients with chronic heart failure: A meta-analysis
-
L. Zhang, Y. Lu, and H. Jiang Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis J Am Coll Cardiol 59 2012 913 922
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 913-922
-
-
Zhang, L.1
Lu, Y.2
Jiang, H.3
-
97
-
-
33645466318
-
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
-
G. Fragasso, G. Perseghin, and F. De Cobelli Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure Eur Heart J 27 2006 942 948
-
(2006)
Eur Heart J
, vol.27
, pp. 942-948
-
-
Fragasso, G.1
Perseghin, G.2
De Cobelli, F.3
-
98
-
-
84874063767
-
Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction: Results from the RALI-DHF study (abstr)
-
L. Maier, R. Wachter, and F. Edelmann Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction: results from the RALI-DHF study (abstr) J Am Coll Cardiol 59 2012 E865
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 865
-
-
Maier, L.1
Wachter, R.2
Edelmann, F.3
-
99
-
-
67149146438
-
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised open-label trial
-
for the RECORD Study Team
-
P.D. Home, S.J. Pocock, H. Beck-Nielsen for the RECORD Study Team Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised open-label trial Lancet 373 2009 2125 2135
-
(2009)
Lancet
, vol.373
, pp. 2125-2135
-
-
Home, P.D.1
Pocock, S.J.2
Beck-Nielsen, H.3
-
100
-
-
84870248203
-
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population
-
W. Doehner, E. Erdmann, and R. Cairns Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population Int J Cardiol 162 2012 20 26
-
(2012)
Int J Cardiol
, vol.162
, pp. 20-26
-
-
Doehner, W.1
Erdmann, E.2
Cairns, R.3
-
101
-
-
13444272949
-
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: An observational study
-
F.A. Masoudi, S.E. Inzucchi, and Y. Wang Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
-
(2005)
Circulation
, vol.111
, pp. 583-590
-
-
Masoudi, F.A.1
Inzucchi, S.E.2
Wang, Y.3
-
102
-
-
84867706737
-
The effect of metformin on insulin resistance and exercise parameters in patients with heart failure
-
A.K. Wong, R. Symon, and M.A. Alzadjali The effect of metformin on insulin resistance and exercise parameters in patients with heart failure Eur J Heart Fail 14 2012 1303 1310
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 1303-1310
-
-
Wong, A.K.1
Symon, R.2
Alzadjali, M.A.3
-
103
-
-
0036791054
-
Metformin in patients with type 2 diabetes mellitus: Reconsideration of traditional contraindications
-
R. Rachmani, I. Slavachevski, and Z. Levi Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications Eur J Intern Med 13 2002 428
-
(2002)
Eur J Intern Med
, vol.13
, pp. 428
-
-
Rachmani, R.1
Slavachevski, I.2
Levi, Z.3
-
104
-
-
84878018230
-
Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
-
S.P. Romero, J.L. Andrey, and A. Garcia-Egido Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community Int J Cardiol 166 2013 404 412
-
(2013)
Int J Cardiol
, vol.166
, pp. 404-412
-
-
Romero, S.P.1
Andrey, J.L.2
Garcia-Egido, A.3
-
105
-
-
84883765959
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
-
for the SAVOR-TIMI Steering Committee and Investigators
-
B.M. Scirica, D.L. Bhatt, E. Braunwald for the SAVOR-TIMI Steering Committee and Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
-
(2013)
N Engl J Med
, vol.369
, pp. 1317-1326
-
-
Scirica, B.M.1
Bhatt, D.L.2
Braunwald, E.3
-
106
-
-
84885322271
-
Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?
-
J. Nagendran, G.Y. Oudit, and J.A. Bakal Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes? Diabetes Obes Metab 15 2013 1022 1028
-
(2013)
Diabetes Obes Metab
, vol.15
, pp. 1022-1028
-
-
Nagendran, J.1
Oudit, G.Y.2
Bakal, J.A.3
-
107
-
-
21144434217
-
Extension of murine life span by overexpression of catalase targeted to mitochondria
-
S.E. Schriner, N.J. Linford, and G.M. Martin Extension of murine life span by overexpression of catalase targeted to mitochondria Science 308 2005 1909 1911
-
(2005)
Science
, vol.308
, pp. 1909-1911
-
-
Schriner, S.E.1
Linford, N.J.2
Martin, G.M.3
-
108
-
-
67649204729
-
Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging
-
D.F. Dai, L.F. Santana, and M. Vermulst Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging Circulation 119 2009 2789 2797
-
(2009)
Circulation
, vol.119
, pp. 2789-2797
-
-
Dai, D.F.1
Santana, L.F.2
Vermulst, M.3
-
109
-
-
4544370680
-
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
-
K. Zhao, G.M. Zhao, and D. Wu Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J Biol Chem 279 2004 34682 34690
-
(2004)
J Biol Chem
, vol.279
, pp. 34682-34690
-
-
Zhao, K.1
Zhao, G.M.2
Wu, D.3
-
110
-
-
79959525058
-
Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy
-
D.F. Dai, T. Chen, and H. Szeto Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy J Am Coll Cardiol 58 2011 73 82
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 73-82
-
-
Dai, D.F.1
Chen, T.2
Szeto, H.3
-
111
-
-
84883807865
-
Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice
-
M.P. Siegel, S.E. Kruse, and J.M. Percival Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice Aging Cell 12 2013 763 771
-
(2013)
Aging Cell
, vol.12
, pp. 763-771
-
-
Siegel, M.P.1
Kruse, S.E.2
Percival, J.M.3
-
112
-
-
84887454400
-
Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides
-
D.F. Dai, E.J. Hsieh, and T. Chen Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides Circ Heart Fail 6 2013 1067 1076
-
(2013)
Circ Heart Fail
, vol.6
, pp. 1067-1076
-
-
Dai, D.F.1
Hsieh, E.J.2
Chen, T.3
-
113
-
-
0026610468
-
Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant
-
K. Folkers, P. Langsjoen, and P.H. Langsjoen Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant Biochem Biophys Res Commun 182 1992 247 253
-
(1992)
Biochem Biophys Res Commun
, vol.182
, pp. 247-253
-
-
Folkers, K.1
Langsjoen, P.2
Langsjoen, P.H.3
-
114
-
-
33750134250
-
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure
-
S. Sander, C.I. Coleman, and A.A. Patel The impact of coenzyme Q10 on systolic function in patients with chronic heart failure J Card Fail 12 2006 464 472
-
(2006)
J Card Fail
, vol.12
, pp. 464-472
-
-
Sander, S.1
Coleman, C.I.2
Patel, A.A.3
-
115
-
-
84857275217
-
Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts
-
G.A. Hirsch, P.A. Bottomley, and G. Gerstenblith Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts J Am Coll Cardiol 59 2012 802 808
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 802-808
-
-
Hirsch, G.A.1
Bottomley, P.A.2
Gerstenblith, G.3
-
116
-
-
20044363683
-
Xanthine oxidase inhibition for chronic heart failure: Is allopurinol the next therapeutic advance in heart failure?
-
W. Doehner, and S.D. Anker Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure? Heart 91 2005 707 709
-
(2005)
Heart
, vol.91
, pp. 707-709
-
-
Doehner, W.1
Anker, S.D.2
-
117
-
-
68949215869
-
Association between allopurinol and mortality in heart failure patients: A long-term follow-up study
-
L. Wei, T. Fahey, and A.D. Struthers Association between allopurinol and mortality in heart failure patients: a long-term follow-up study Int J Clin Pract 63 2009 1327 1333
-
(2009)
Int J Clin Pract
, vol.63
, pp. 1327-1333
-
-
Wei, L.1
Fahey, T.2
Struthers, A.D.3
-
118
-
-
44649122196
-
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study
-
for the OPT-CHF Investigators
-
J.M. Hare, B. Mangal, J. Brown for the OPT-CHF Investigators Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 2301-2309
-
-
Hare, J.M.1
Mangal, B.2
Brown, J.3
-
119
-
-
0029817697
-
Hemodynamic effects of creatine phosphate in patients with congestive heart failure: A double-blind comparison trial versus placebo
-
S. Ferraro, C. Codella, and F. Palumbo Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo Clin Cardiol 19 1996 699 703
-
(1996)
Clin Cardiol
, vol.19
, pp. 699-703
-
-
Ferraro, S.1
Codella, C.2
Palumbo, F.3
-
120
-
-
79953698833
-
Coenzyme Q10 terclatrate and creatine in chronic heart failure: A randomized, placebo-controlled, double-blind study
-
S. Fumagalli, F. Fattirolli, and L. Guarducci Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study Clin Cardiol 34 2011 211 217
-
(2011)
Clin Cardiol
, vol.34
, pp. 211-217
-
-
Fumagalli, S.1
Fattirolli, F.2
Guarducci, L.3
-
121
-
-
0025639897
-
Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure
-
Y. Masumura, A. Kobayashi, and N. Yamazaki Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure Jpn Circ J 54 1990 1471 1476
-
(1990)
Jpn Circ J
, vol.54
, pp. 1471-1476
-
-
Masumura, Y.1
Kobayashi, A.2
Yamazaki, N.3
-
122
-
-
84880197534
-
L-carnitine in the secondary prevention of cardiovascular disease: Systematic review and meta-analysis
-
J.J. DiNicolantonio, C.J. Lavie, and H. Fares L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis Mayo Clin Proc 88 2013 544 551
-
(2013)
Mayo Clin Proc
, vol.88
, pp. 544-551
-
-
Dinicolantonio, J.J.1
Lavie, C.J.2
Fares, H.3
-
123
-
-
28944442442
-
Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial
-
C.J. Malkin, P.J. Pugh, and J.N. West Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial Eur Heart J 27 2006 57 64
-
(2006)
Eur Heart J
, vol.27
, pp. 57-64
-
-
Malkin, C.J.1
Pugh, P.J.2
West, J.N.3
-
124
-
-
84864477617
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
-
J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur J Heart Fail 14 2012 803 869
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
|